Literature DB >> 31206997

NICE Guidance - Prostate cancer: diagnosis and management: © NICE (2019) Prostate cancer: diagnosis and management.

.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31206997     DOI： 10.1111/bju.14809

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  8 in total

1.  Identification of G2 and S Phase-Expressed-1 as a Potential Biomarker in Patients with Prostate Cancer.

Authors:  Jian Xiong; Jianzhong Zhang; Hongjun Li
Journal:  Cancer Manag Res       Date:  2020-09-28       Impact factor: 3.989

Review 2.  Patients with Positive Lymph Nodes after Radical Prostatectomy and Pelvic Lymphadenectomy-Do We Know the Proper Way of Management?

Authors:  Bartosz Małkiewicz; Miłosz Knura; Małgorzata Łątkowska; Maximilian Kobylański; Krystian Nagi; Dawid Janczak; Joanna Chorbińska; Wojciech Krajewski; Jakub Karwacki; Tomasz Szydełko
Journal:  Cancers (Basel)       Date:  2022-05-08       Impact factor: 6.575

3.  Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?

Authors:  Xueqing Cheng; Jinshun Xu; Yuntian Chen; Zhenhua Liu; Guangxi Sun; Ling Yang; Jin Yao; Hao Zeng; Bin Song
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

4.  Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study.

Authors:  Giorgio Brembilla; Francesco Giganti; Harbir Sidhu; Massimo Imbriaco; Sue Mallett; Armando Stabile; Alex Freeman; Hashim U Ahmed; Caroline Moore; Mark Emberton; Shonit Punwani
Journal:  Diagnostics (Basel)       Date:  2022-01-18

5.  Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0).

Authors:  Otto Ettala; Ivan Jambor; Ileana Montoya Perez; Marjo Seppänen; Antti Kaipia; Heikki Seikkula; Kari T Syvänen; Pekka Taimen; Janne Verho; Aida Steiner; Jani Saunavaara; Ekaterina Saukko; Eliisa Löyttyniemi; Daniel D Sjoberg; Andrew Vickers; Hannu Aronen; Peter Boström
Journal:  BMJ Open       Date:  2022-04-15       Impact factor: 3.006

6.  Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer.

Authors:  Mark Paxton; Eitan Barbalat; Nathan Perlis; Ravi J Menezes; Mark Gertner; David Dragas; Masoom A Haider; Antonio Finelli; John Trachtenberg; Sangeet Ghai
Journal:  Br J Radiol       Date:  2021-07-29       Impact factor: 3.039

7.  Australian ultrasound-guided biopsy trends: a 17-year analysis of national data.

Authors:  Lachlan A N Gordon; Jonathan Kam; Daniel Gilbourd; Hodo Haxhimolla
Journal:  Prostate Int       Date:  2019-10-21

8.  Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance.

Authors:  Nikita Sushentsev; Leonardo Rundo; Oleg Blyuss; Tatiana Nazarenko; Aleksandr Suvorov; Vincent J Gnanapragasam; Evis Sala; Tristan Barrett
Journal:  Eur Radiol       Date:  2021-07-13       Impact factor: 5.315
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.